Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - September 2013


Your body is 3D, why is your cell culture not?

27 Sep 2013 - 27 Sep 2013 - Webinar



Bookmark and Share


3D cell-based applications close the gap between conventional in-vitro approaches and in vivo animal model research. By automating the 3D cell culture process and assay detection in a microplate based format, this significantly shortens development time of new drug candidates as well as offering more reliable statistical results.   

Tecan will present solutions for 3D cell culture systems using the Alvetex (Reinnervate), RAFT (TAP Biosystems)  scaffold based, and GravityPlus (InSphero) scaffold-free technology. In particular, automating a 3D cell culture system with the Freedom EVO® liquid handling platform offers a simple and reliable approach for cultivation, and the Infinite M-200 PRO multi-detection reader with its Optimal Read function in conjunction with the patent pending Gas Control Module (GCMTM) offers an excellent solution for acute and chronic toxicity tests, as well as multiplexed assays in cancer research.

Presenter:
Christian Oberdanner, PhD
Application Specialist Sales & Marketing, Tecan Austria GmbH

Christian Oberdanner, PhD, studied Molecular- and Cell-Biology at the University of Salzburg, Austria. In his doctoral thesis he focused on Reactive Oxygen Species-mediated apoptosis induction in photodynamic cancer therapy. 

Christian started to work for Tecan Austria as an external scientific consultant already during his last year at University. After his graduation he joined Tecan as Application Specialist in the department for research and development but quickly changed to the sales and marketing department. His expertise is on applications for Tecan’s multimode readers and microplate washers but he is also contributing to new product developments as a Junior Product Manager.


Further information
Scientific News
Liquid Biopsies: Utilization of Circulating Biomarkers for Minimally Invasive Diagnostics Development
Market Trends in Biofluid-based Liquid Biopsies: Deploying Circulating Biomarkers in the Clinic. Enal Razvi, Ph.D., Managing Director, Select Biosciences, Inc.
Study Questions Presence in Blood of Heart-Healthy Molecules from Fish Oil Supplements
A new study from the Perelman School of Medicine at the University of Pennsylvania questions the relevance of fish oil-derived SPMs and their purported anti-inflammatory effects in humans.
Experimental MERS Vaccine Shows Promise in Animal Studies
A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines.
Young South African Women can Adhere to Daily PrEP Regimen as HIV Prevention
NIH-funded study finds men in Bangkok, Harlem also successful in taking daily dose.
Key Player in Diabetic Kidney Disease Revealed
Discovery could lead to new and better diagnostic marker for chronic kidney disease.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Santhera Announces First Patient Dosing with Omigapil in CMD
Company announces full patient recruitment of CALLISTO study.
Study Shows Promise of Precision Medicine for Most Common Type of Lymphoma
The study appeared online July 20, 2015, in Nature Medicine.
HIV Control Through Treatment Durably Prevents Heterosexual Transmission of Virus
NIH-funded trial proves suppressive antiretroviral therapy for HIV-infected people effective in protecting uninfected partners.
Adaptimmune's Novel Cancer Therapeutics Show Positive Clinical Trial Results
The company has announced that positive data from its Phase I/II study of its affinity enhanced T-cell receptor (TCR) therapeutic targeting the NY-ESO-1 cancer antigen in patients with multiple myeloma has been published.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!